Synergy Between Food and Pharma Driving South America’s Economy

UBM live has announced that this year’s recent CPHI South America, which took place 6–8 August, at the Expo Center Norte in São Paulo proved to be the foremost event for collaborating two integral industries and providing the opportunity to form symbiotic partnerships with industry leaders to shape the collective markets.

South America is undergoing a changing macro-economic environment, with a burgeoning middle-class and heightened job opportunities, which in turn has lead to an increased demand for healthcare and the pharmaceutical industry in general. In Brazil alone, according to information published by the Brazilian Ministry of Health, the pharmaceutical market turns over R$28billion annually and it is forecast to reach to R$87billion by 2017. This budding economy proves that there has never been a better time to invest in the South American pharma market and CPHI provided the ideal platform for companies to meet with domestic buyers and suppliers, whilst also creating a networking opportunity to foster international partnerships.

Embarking upon it’s sixth successful edition, CPHI South America joined forces with Food Ingredients South America (FiSA) & Health Ingredients South America (HiSA), the region’s other primary super-conferences, to help stimulate further economic development within South America. The collaborative events attracted many international exhibitors representing the whole supply chain from countries including the US, Germany, Canada, Japan, China and India who were all keen to break into the South American market, and were pivotal in driving economical growth and innovation throughout the region. Signifying the importance of the co-located shows, attendance figures reached around 10,000 strong, which is the most successful turn out to date.

Throughout the three show days an attractive series of lectures were presented, covering the current pharmaceutical industry trends and perspectives and keeping attendees up to date on subjects ranging from Drug Master Files (DMFs) to open innovation and legal procedures. Workshops, international business round tables and seminars were also offered, of which proved particularly valuable to international exhibitors and featured hot topics such as “How to understand regulatory issues in Brazil”, conducted by ABRIFAR. An overview of the regulatory affairs in Brazil was provided showcasing the favourable regulatory environment which no doubt makes it an ideal place for international companies to build partnerships and establish themselves.

Furthermore, a particular highlight of this year’s show was the model laboratory, which all attendees were able to experience and learn more about equipment on offer. The lab presented modern equipment for analysis and production of tablets, preformulation testing and development of solid pharmaceutical forms.

Erik Heemskerk, Brand Director Emerging Markets at UBM Live commented: “Latin America is one of the fastest growing regions for the pharmaceutical industry and is increasingly becoming a go-to destination for international companies looking to establish themselves in and form domestic partnerships with, particularly as the regulatory environment in so favorable. CPHI and its co-located events showed just how significant the synergy between pharma and food is and highlighted the growth opportunities that these two industries can provide when collaborating. The partnership is becoming more necessary as we see nutraceuticals and supplements play a pivotal role within the healthcare sector. We are delighted with the turnout at CPHI South America and look forward to returning next year to provide a perfect gateway to this booming market.”

CPHI South America 2014, with co-located events ICSE and BioPh, will return alongside FiSA and HiSA, on 5–7 August 2014, at the Expo Centre Norte in Sao Paulo.

The UBM Live annual schedule of Pharmaceutical events also includes CPHI Worldwide, ICSE, P-MEC Europe and InnoPack (22–24 October, 2013 at Messe Frankfurt, Germany); CPHI and P-MEC India (3–5 December, 2013 at the Bombay Exhibition Centre in Mumbai); CPHI, ICSE, P-MEC, BioPh and Pharmatec Japan (9–11 April, 2014 in Tokyo); CPHI Russia and IPhEB (16–17 April, 2014 in St Petersburg, Russia); CPHI, P-MEC and Innopack South East Asia (20–22 May, 2014 in Jakarta, Indonesia); CPHI Istanbul (4–6 June, 2014, Turkey) and CPHI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26–28 June, 2014 at SNIEC, Shanghai, China).